Keyphrases
Experimental Validation
100%
Alzheimer
100%
MicroRNA
100%
ADAM10
100%
MiR-107
100%
Computational Identification
100%
Identification Validation
100%
Alzheimer's Disease
81%
Selection Criteria
18%
3′-untranslated Region (3′-UTR)
18%
AlzGene
18%
Publicly Available
9%
Evolutionary
9%
Disease-associated
9%
Gene Ontology Analysis
9%
SH-SY5Y Cells
9%
Computational Approach
9%
Prediction Process
9%
Miranda
9%
Binding Site
9%
Therapeutic Treatment
9%
Luciferase Assay
9%
MiRNA Target
9%
Tissue Expression
9%
Biological Processes
9%
Literature Mining
9%
Differential Regulation
9%
Cancer Cell Lines
9%
Post-transcriptional Regulator
9%
Proteolytic Processing
9%
Amyloid Plaques
9%
RNA-binding Domain
9%
Reporter Assay
9%
RNA Hybrid
9%
Target Site Prediction
9%
Hepatic Cancer Cells
9%
MiRNA-22
9%
Alzheimer's Disease Patient
9%
Predicted Target Genes
9%
Neuroscience
MicroRNA
100%
microRNA 107
100%
Alzheimer's Disease
81%
Binding Site
18%
Cell Line
9%
Untranslated Region
9%
Luciferase
9%
Treatment of Alzheimer's Disease
9%
Proteolytic Processing
9%
Amyloid Protein
9%
3' Untranslated Region
9%
Biochemistry, Genetics and Molecular Biology
MicroRNA
100%
ADAM10
100%
Binding Site
25%
Proteolytic Processing
12%
Cancer Cell
12%
Gene Ontology
12%
3' Untranslated Region
12%
Biological Phenomena and Functions Concerning the Entire Organism
12%
Untranslated Region
12%
Luciferase
12%
Amyloid Protein
12%
Immunology and Microbiology
ADAM10
100%
Binding Site
28%
Proteolytic Processing
14%
Cancer Cell Line
14%
Biological Phenomena and Functions Concerning the Entire Organism
14%
Gene Ontology
14%
3' Untranslated Region
14%
Untranslated Region
14%